polymath
Bluelight Crew
Is there any evidence that naproxen would be self-administered by lab animals? Saying it can cause euphoria is a bit dangerous if it makes people consume huge doses of it and get a bleeding ulcer...
N&PD Moderators: Skorpio | someguyontheinternet
Naproxen especially has psychoactive effects
I suppose I had forgotten that MAO-B inhibitors aren't really serotonergic. Selegiline/rasagiline thus count. Interestingly p-benzyloxyamphetamine is a reversible (kinda) selective MAO-B inhibitor, cf https://www.sciencedirect.com/science/article/pii/S0968089609001333 (Table 2, entry 3f).
Nefopam is an SNRI and 5-ht2c antagonist, so it resembles both SNRIs and agomelatine.
I think ketamine is an SNDRI. And an opioid agonist. Yeesh.
If you were 'deficient in dopamine' you would present with Parkinsons, not depression.
Nowadays amphetamine is only rarely if ever prescribed as an antidepressant. It would be more accurate to say that at such high dosages it's more of a recreational euphoriant drug than a true antidepressant. Antidepressants are not supposed to make you feel like some sort of Ubermensch, nor are they supposed to make you Always Feeling Good, they are meant to restore normal emotional functioning.
But that antidepressants rarely make you feel euphoric is due to the fact that most antidepressants are serotonergic and not because there is something magical about antidepressants that restore "normal" mood but don't make you feel good. Back in the 1970's there were two antidepressants, nomifensine and amineptine, which were notorious for inducing mild euphoria. They made people feel slightly euphoric because they are inhibitors of the reuptake of norepinephrine and dopamine. That is, their mechanism of action was similar to cocaine, although with weaker adrenergic action. The non-selective MAOIs are also notorious for making people feel "better than well", and the reason for that, among other things, is that they increase norepinephrine and dopamine and not only serotonin. In fact, that the MAOIs increase dopamine is the reason why Dr.Gillman favors tranylcypromine and phenelzine over all other antidepressants for treating serious depression.
The problem with this is that it can make people hyperactive and sexually promiscuous in a way that family members find disturbing... One of the things that are a problem just because not everyone is like that.
Some people have synthesized combined mu agonist/substance P antagonist compounds, and then there doesn't seem to develop tolerance to the opioid effect. Make that a kappa receptor blocker too, and you'd have a great antidepressant.
3-Iodobenzoyl naltrexamine (IBNtxA) is a potent analgesic belonging to the pharmacologically diverse 6β-amidoepoxymorphinan group of opioids. We present the synthesis and pharmacological evaluation of five analogs of IBNtxA. The scaffold of IBNtxA was modified by removing the 14-hydroxy group, incorporating a 7,8 double bond and various N-17 alkyl substituents. The structural modifications resulted in analogs with picomolar affinities for opioid receptors. The lead compound (MP1104) was found to exhibit approximately 15-fold greater antinociceptive potency (ED50 = 0.33 mg/kg) compared with morphine, mediated through the activation of kappa- and delta-opioid receptors. Despite its kappa agonism, this lead derivative did not cause place aversion or preference in mice in a place-conditioning assay, even at doses 3 times the analgesic ED50. However, pretreatment with the lead compound prevented the reward behavior associated with cocaine in a conditioned place preference assay. Together, these results suggest the promise of dual acting kappa- and delta-opioid receptor agonists as analgesics and treatments for cocaine addiction.